Furthermore, a number of ferroptosis gene signatures, including genes such as FTH1, GPX4, STEAP3, LPCAT3 and others, have been developed to predict prognosis and overall survival in patients with DLBCL [76,77,78]. This evidence concerns the gene GPX4 and diffuse large B-cell lymphoma.